Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

Similar articles for PubMed (Select 23337469)

1.

Resistant hypertension? Assessment of adherence by toxicological urine analysis.

Jung O, Gechter JL, Wunder C, Paulke A, Bartel C, Geiger H, Toennes SW.

J Hypertens. 2013 Apr;31(4):766-74. doi: 10.1097/HJH.0b013e32835e2286.

PMID:
23337469
2.

High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis.

Tomaszewski M, White C, Patel P, Masca N, Damani R, Hepworth J, Samani NJ, Gupta P, Madira W, Stanley A, Williams B.

Heart. 2014 Jun;100(11):855-61. doi: 10.1136/heartjnl-2013-305063. Epub 2014 Apr 2.

3.

Characteristics, drug combinations and dosages of primary care patients with uncontrolled ambulatory blood pressure and high medication adherence.

Grigoryan L, Pavlik VN, Hyman DJ.

J Am Soc Hypertens. 2013 Nov-Dec;7(6):471-6. doi: 10.1016/j.jash.2013.06.004. Epub 2013 Jul 23.

4.

Resistant hypertension revisited: a comparison of two university-based cohorts.

Garg JP, Elliott WJ, Folker A, Izhar M, Black HR; RUSH University Hypertension Service.

Am J Hypertens. 2005 May;18(5 Pt 1):619-26.

PMID:
15882544
5.

Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy.

Ceral J, Habrdova V, Vorisek V, Bima M, Pelouch R, Solar M.

Hypertens Res. 2011 Jan;34(1):87-90. doi: 10.1038/hr.2010.183. Epub 2010 Sep 30.

PMID:
20882030
6.

Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions.

Burnier M, Schneider MP, Chioléro A, Stubi CL, Brunner HR.

J Hypertens. 2001 Feb;19(2):335-41.

PMID:
11212978
8.
9.

[Problems of a physician-patient interaction and control of arterial hypertension in Russia. Main results of scientific-practical program ARGUS-2].

Kobalava ZhD, Kotovskaia IuV, Starostina EG, Villeval'de SV, Luk'ianova EA, Serebrennikovca ON, Maslova IM, Baranova EI, Bogachev RS, Volkova NI, Drozdetskiĭ SI, Kisliak OA, Koziolova NA, Kolina IG, Krasnova IuN, Lopatin IuM, Nedogoda SV, Tarlovskaia EI, Tiukalova LI, Khokhlov RA, Freĭdlina MA.

Kardiologiia. 2007;47(3):38-47. Russian.

PMID:
17495848
10.

Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis.

Strauch B, Petrák O, Zelinka T, Rosa J, Somlóová Z, Indra T, Chytil L, Marešová V, Kurcová I, Holaj R, Wichterle D, Widimský J Jr.

J Hypertens. 2013 Dec;31(12):2455-61. doi: 10.1097/HJH.0b013e3283652c61.

PMID:
24220593
11.

Initial treatment of hypertension and adherence to therapy in general practice in Italy.

Poluzzi E, Strahinja P, Vargiu A, Chiabrando G, Silvani MC, Motola D, Sangiorgi Cellini G, Vaccheri A, De Ponti F, Montanaro N.

Eur J Clin Pharmacol. 2005 Sep;61(8):603-9. Epub 2005 Aug 5.

PMID:
16082539
12.

Assessment of adherence to treatment in patients with resistant hypertension using toxicological serum analysis. A subgroup evaluation of the RESIST-POL study.

Florczak E, Tokarczyk B, Warchoł-Celińska E, Szwench-Pietrasz E, Prejbisz A, Gosk M, Kabat M, Narkiewicz K, Januszewicz A, Kała M.

Pol Arch Med Wewn. 2015;125(1-2):65-72. Epub 2015 Jan 12.

13.

Monitoring compliance in resistant hypertension: an important step in patient management.

Burnier M, Santschi V, Favrat B, Brunner HR.

J Hypertens Suppl. 2003 May;21(2):S37-42. Review.

PMID:
12929906
14.

Factors associated with drug adherence and blood pressure control in patients with hypertension.

Morris AB, Li J, Kroenke K, Bruner-England TE, Young JM, Murray MD.

Pharmacotherapy. 2006 Apr;26(4):483-92.

PMID:
16553506
15.

Hypertension treatment in a medicare population: adherence and systolic blood pressure control.

Fung V, Huang J, Brand R, Newhouse JP, Hsu J.

Clin Ther. 2007 May;29(5):972-84.

PMID:
17697916
16.

Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.

Lee JY, Kusek JW, Greene PG, Bernhard S, Norris K, Smith D, Wilkening B, Wright JT Jr.

Am J Hypertens. 1996 Aug;9(8):719-25.

PMID:
8862216
17.

Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension.

Veglio F, Rabbia F, Riva P, Martini G, Genova GC, Milan A, Paglieri C, Carra R, Chiandussi L.

Clin Exp Hypertens. 2001 Apr;23(3):203-11.

PMID:
11339687
18.

[Compliance problems in therapy resistant hypertension].

Werlemann BC, Offers E, Kolloch R.

Herz. 2004 May;29(3):271-5. German.

PMID:
15167953
19.

Resistant hypertension and the neglected antihypertensive: sodium restriction.

Agarwal R.

Nephrol Dial Transplant. 2012 Nov;27(11):4041-5. doi: 10.1093/ndt/gfs384. Epub 2012 Aug 16. Review.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk